Brad Brumbaugh, CFA
Director
Brad Brumbaugh, Director at Helix Health Capital Advisors, specializes in guiding healthcare companies and investors through complex M&A, capital raising, and strategic financial decisions. He brings over a decade of experience in healthcare deals at firms such as PwC, VMG Health, and Berkeley Research Group, where he has advised a diverse range of clients, from Fortune 500 companies and major health systems to specialized provider groups and innovative startups.
Additionally, Brad has held leadership roles in PE-backed entities, including US Anesthesia Partners and a healthcare AI startup, where he focused on strategic finance, corporate development, and value creation.
Brad's unique combination of advisory and operational expertise gives him a distinct perspective, enhancing his advisory strategies with practical insights and bespoke solutions tailored to the dynamic healthcare landscape.
Prior Work Experience
Eon — SVP, Finance | Healthcare Corporate Finance
PwC — Senior Manager | Healthcare M&A Advisory
US Anesthesia Partners — Manager, Finance | Healthcare Corporate Finance
VMG Health — Manager | Healthcare M&A Advisory
Berkeley Research Group — Senior Associate | Healthcare M&A Advisory
Ascendient Healthcare Advisors — Senior Consultant | Healthcare M&A Advisory
Education
MBA, The Wharton School, University of Pennsylvania
CFA Charterholder
BS, Finance, summa cum laude, East Carolina University
Board & Community Involvement
Board Member, CFA Society of Colorado (2019-2024)
Contact Us
Looking for expert guidance on healthcare M&A or strategic opportunities? Connect with our team for tailored advice and support.